Department of Neurological Surgery, University of Southern California, Los Angeles, California.
Neurosurgery. 2019 Mar 1;84(3):726-732. doi: 10.1093/neuros/nyy187.
Hospital readmissions are commonly linked to elevated health care costs, with significant financial incentive introduced by the Affordable Care Act to reduce readmissions.
To study the association between patient, hospital, and payer factors with national rate of readmission in acoustic neuroma surgery.
All adult inpatients undergoing surgery for acoustic neuroma in the newly introduced Nationwide Readmissions Database from 2013 to 2014 were included. We identified readmissions for any cause with a primary diagnosis of neurological, surgical, or systemic complication within 30- and 90-d after undergoing acoustic neuroma surgery. Multivariable models were employed to identify patient, hospital, and administrative factors associated with readmission. Hospital volume was measured as the number of cases per year.
We included patients representing a weighted estimate of 4890 admissions for acoustic neuroma surgery in 2013 and 2014, with 355 30-d (7.7%) and 341 90-d (9.1%) readmissions. After controlling for patient, hospital, and payer factors, procedural volume was significantly associated with 30-d readmission rate (OR [odds ratio] 0.992, p = 0.03), and 90-d readmission rate (OR 0.994, p = 0.047). The most common diagnoses during readmission in both 30- and 90-d cohorts included general central nervous system complications/deficits, hydrocephalus, infection, and leakage of cerebrospinal fluid (rhinorrhea/otorrhea).
After controlling for patient, hospital, and payer factors, increased procedural volume is associated with decreased 30- and 90-d readmission rate for acoustic neuroma surgery. Future studies seeking to improve outcomes and reduce cost in acoustic neuroma surgery may seek to further evaluate the role of hospital procedural volume and experience.
医院再入院通常与医疗费用增加有关,《平价医疗法案》引入了重大的经济激励措施,以降低再入院率。
研究患者、医院和支付方因素与听神经瘤手术国家再入院率之间的关联。
纳入 2013 年至 2014 年新引入的全国再入院数据库中所有接受听神经瘤手术的成年住院患者。我们确定了任何原因导致的再入院,主要诊断为神经系统、外科或系统性并发症,发生在接受听神经瘤手术后 30 天和 90 天内。采用多变量模型确定与再入院相关的患者、医院和管理因素。医院容量以每年的病例数衡量。
我们纳入了代表 2013 年和 2014 年听神经瘤手术加权估计值为 4890 例的患者,其中 355 例发生 30 天(7.7%)和 341 例发生 90 天(9.1%)再入院。在控制患者、医院和支付方因素后,手术量与 30 天再入院率显著相关(OR [比值比]0.992,p=0.03),与 90 天再入院率显著相关(OR 0.994,p=0.047)。在 30 天和 90 天队列中,再入院最常见的诊断包括一般中枢神经系统并发症/缺陷、脑积水、感染和脑脊液漏(鼻漏/耳漏)。
在控制患者、医院和支付方因素后,手术量的增加与听神经瘤手术 30 天和 90 天再入院率的降低相关。未来旨在改善听神经瘤手术结果和降低成本的研究可能需要进一步评估医院手术量和经验的作用。